$UUP
Invesco DB US Dollar Index Bullish Fund

2023 Q1 Form 10-K Financial Statement

#000156459023002350 Filed on February 24, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $15.03M $29.00M
YoY Change 7099.61% 18613.91%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $2.682M $12.08M
YoY Change 71.26% 252.39%
Operating Profit $12.52M $17.67M
YoY Change -1034.53% -653.84%
Interest Expense $45.31K $104.6K
YoY Change 4595.65% 4521.95%
% of Operating Profit 0.36% 0.59%
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax
% Of Pretax Income
Net Earnings $4.296M $81.27M
YoY Change -81.76% 256.28%
Net Earnings / Revenue 28.58% 280.27%
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 52.90M
Diluted Shares Outstanding

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $0.00 $5.578M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $1.133B $1.658B
YoY Change 130.12%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $6.323M $14.54M
YoY Change 359.48%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.126B $1.643B
YoY Change
Total Liabilities & Shareholders Equity $1.133B $1.658B
YoY Change 130.12%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income $4.296M $81.27M
YoY Change -81.76% 256.28%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities $518.7M -$847.6M
YoY Change -355.45% 158.15%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $16.18M
YoY Change
Common Stock Issuance & Retirement, Net -$869.4M
YoY Change 164.78%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -524.3M 853.2M
YoY Change -358.2% 159.85%
NET CHANGE
Cash From Operating Activities 518.7M -847.6M
Cash From Investing Activities
Cash From Financing Activities -524.3M 853.2M
Net Change In Cash -5.578M 5.578M
YoY Change
FREE CASH FLOW
Cash From Operating Activities $518.7M -$847.6M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Auditor Firm
AuditorFirmId
238
CY2022Q2 dei Entity Public Float
EntityPublicFloat
1725132000
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
52900000
CY2021Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
92006259
CY2022Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
983150588
CY2021Q4 us-gaap Investments In And Advances To Affiliates At Fair Value
InvestmentsInAndAdvancesToAffiliatesAtFairValue
626458758
CY2021Q4 uup Receivable For Due From Broker
ReceivableForDueFromBroker
2034654
CY2022Q4 us-gaap Dividends Receivable
DividendsReceivable
2846903
CY2021Q4 us-gaap Dividends Receivable
DividendsReceivable
9990
CY2022Q4 us-gaap Assets
Assets
1658007047
CY2021Q4 us-gaap Assets
Assets
720509661
CY2022Q4 uup Payable To Clearing Organizations
PayableToClearingOrganizations
5052204
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1863160467
CY2020 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1670963139
CY2020 uup Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
192197328
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
366185815
CY2021 us-gaap Interest Paid Net
InterestPaidNet
2264
CY2021 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
26003026
CY2020 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
-52884359
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22812199
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-54328730
CY2021 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
755794494
CY2021 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
427447338
CY2021 uup Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
328347156
CY2022 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
66941682
CY2021 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
26425686
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
-50872611
CY2021 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-5074
CY2020 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
-42469
CY2020 uup Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
103882
CY2021 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
82133
CY2020 uup Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
5.00
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Entity File Number
EntityFileNumber
001-33314
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0778082
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
Invesco Capital Management LLC
CY2022 dei Entity Address Address Line2
EntityAddressAddressLine2
3500 Lacey Road
CY2022 dei Entity Address Address Line3
EntityAddressAddressLine3
Suite 700
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2022 dei City Area Code
CityAreaCode
800
CY2022 dei Local Phone Number
LocalPhoneNumber
83-0903
CY2022 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2022 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
false
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2022 dei Auditor Name
AuditorName
PricewaterhouseCoopers LLP
CY2022 dei Auditor Location
AuditorLocation
Chicago, Illinois
CY2022Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
666431938
CY2022Q4 us-gaap Cash
Cash
5577618
CY2021Q4 uup Payable To Clearing Organizations
PayableToClearingOrganizations
2784355
CY2022Q4 uup Payable For Fund Shares Reacquired
PayableForFundSharesReacquired
8358688
CY2022Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1125769
CY2021Q4 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
376104
CY2022Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
3655
CY2021Q4 us-gaap Commissions Payable To Broker Dealers And Clearing Organizations
CommissionsPayableToBrokerDealersAndClearingOrganizations
4032
CY2022Q4 us-gaap Liabilities
Liabilities
14540316
CY2021Q4 us-gaap Liabilities
Liabilities
3164491
CY2022Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
1112
CY2021Q4 us-gaap General Partners Capital Account
GeneralPartnersCapitalAccount
1025
CY2022Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
1643465619
CY2021Q4 us-gaap Limited Partners Capital Account
LimitedPartnersCapitalAccount
717344145
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1643466731
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
717345170
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1658007047
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
720509661
CY2022Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2021Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2022Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
59100000
CY2021Q4 us-gaap Limited Partners Capital Account Units Outstanding
LimitedPartnersCapitalAccountUnitsOutstanding
28000000
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.81
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.62
CY2022Q4 uup Market Value Per Share
MarketValuePerShare
27.81
CY2021Q4 uup Market Value Per Share
MarketValuePerShare
25.63
CY2022Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
1649547064
CY2022Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0037
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1649582526
CY2022Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
99830000
CY2021Q4 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
718493794
CY2021Q4 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
1.0016
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
718465017
CY2021Q4 us-gaap Good Faith And Margin Deposits With Broker Dealers
GoodFaithAndMarginDepositsWithBrokerDealers
27997000
CY2022 us-gaap Interest Income Operating
InterestIncomeOperating
11504581
CY2022 us-gaap Dividend Income Operating
DividendIncomeOperating
17494117
CY2021 us-gaap Dividend Income Operating
DividendIncomeOperating
75059
CY2022 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
28998698
CY2021 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
154958
CY2020 us-gaap Interest And Dividend Income Operating
InterestAndDividendIncomeOperating
2056486
CY2022 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
11622714
CY2021 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
3312762
CY2020 us-gaap Investment Company General Partner Advisory Service
InvestmentCompanyGeneralPartnerAdvisoryService
3868226
CY2022 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
352205
CY2021 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
112892
CY2020 us-gaap Floor Brokerage Exchange And Clearance Fees
FloorBrokerageExchangeAndClearanceFees
151671
CY2022 us-gaap Interest Expense
InterestExpense
104641
CY2021 us-gaap Interest Expense
InterestExpense
2264
CY2020 us-gaap Interest Expense
InterestExpense
6190
CY2022 us-gaap Operating Expenses
OperatingExpenses
12079560
CY2021 us-gaap Operating Expenses
OperatingExpenses
3427918
CY2020 us-gaap Operating Expenses
OperatingExpenses
4026087
CY2022 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
753090
CY2021 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
82133
CY2020 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
525230
CY2022 uup Operating Expenses Net
OperatingExpensesNet
11326470
CY2021 uup Operating Expenses Net
OperatingExpensesNet
3345785
CY2020 uup Operating Expenses Net
OperatingExpensesNet
3500857
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
17672228
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-3190827
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1444371
CY2022 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
3
CY2020 us-gaap Marketable Securities Realized Gain Loss
MarketableSecuritiesRealizedGainLoss
-5188
CY2020 uup Realized Gain Loss On Affiliated Investments
RealizedGainLossOnAffiliatedInvestments
9822
CY2021 uup Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
8454
CY2020 uup Net Realized Gain Loss On Capital Gain Distributions From Affiliated Investments
NetRealizedGainLossOnCapitalGainDistributionsFromAffiliatedInvestments
20471
CY2022 uup Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
66941679
CY2021 uup Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
26417232
CY2020 uup Gain Loss On Sale Of Currency Contracts
GainLossOnSaleOfCurrencyContracts
-50897716
CY2022 us-gaap Marketable Securities Unrealized Gain Loss
MarketableSecuritiesUnrealizedGainLoss
227990
CY2022 uup Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
-163751
CY2021 uup Unrealized Gain Loss On Affiliated Investments
UnrealizedGainLossOnAffiliatedInvestments
-21240
CY2022 uup Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
-3403880
CY2021 uup Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
-396346
CY2020 uup Unrealized Gain Loss On Currency Contracts
UnrealizedGainLossOnCurrencyContracts
-2073161
CY2022 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-3339641
CY2021 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-422660
CY2020 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-2011748
CY2022 us-gaap Investment Company Realized And Unrealized Gain Loss On Investment And Foreign Currency
InvestmentCompanyRealizedAndUnrealizedGainLossOnInvestmentAndForeignCurrency
63602041
CY2022 us-gaap Net Income Loss
NetIncomeLoss
81274269
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
717345170
CY2022 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2623713859
CY2022 us-gaap Stock Redeemed Or Called During Period Value
StockRedeemedOrCalledDuringPeriodValue
1762689597
CY2022 uup Stockholders Equity Period Increase Decrease Due To Share Transactions
StockholdersEquityPeriodIncreaseDecreaseDueToShareTransactions
861024262
CY2022 us-gaap Partners Capital Account Return Of Capital
PartnersCapitalAccountReturnOfCapital
16176970
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
17672228
CY2022 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
66941682
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-192196828
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
16176970
CY2022 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2623713859
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
755794494
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
1863160467
CY2022 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-3339641
CY2022 us-gaap Net Income Loss
NetIncomeLoss
81274269
CY2022 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
926121561
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1643466731
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
366185815
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
-3190827
CY2021 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
26425686
CY2021 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-422660
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22812199
CY2021 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
351159355
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
717345170
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
228317217
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-1444371
CY2020 us-gaap Marketable Securities Realized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments
-50872611
CY2020 us-gaap Marketable Securities Unrealized Gain Loss Excluding Other Than Temporary Impairments
MarketableSecuritiesUnrealizedGainLossExcludingOtherThanTemporaryImpairments
-2011748
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-54328730
CY2020 us-gaap Stockholders Equity Period Increase Decrease
StockholdersEquityPeriodIncreaseDecrease
137868598
CY2022 us-gaap Net Income Loss
NetIncomeLoss
81274269
CY2021 us-gaap Net Income Loss
NetIncomeLoss
22812199
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-54328730
CY2022 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
1984762934
CY2021 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
260947261
CY2020 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
668542085
CY2022 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
1422008100
CY2021 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
289000000
CY2020 us-gaap Proceeds From Sale Of Securities Operating Activities
ProceedsFromSaleOfSecuritiesOperatingActivities
672934371
CY2022 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
3509527927
CY2021 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
1000484866
CY2020 uup Cost Of Affiliated Investments Purchased
CostOfAffiliatedInvestmentsPurchased
2307497397
CY2022 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
3152672346
CY2021 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
619414864
CY2020 uup Proceeds From Affiliated Investments Sold
ProceedsFromAffiliatedInvestmentsSold
2167831112
CY2022 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-11442852
CY2021 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-79890
CY2020 us-gaap Depreciation Amortization And Accretion Net
DepreciationAmortizationAndAccretionNet
-777478
CY2022 uup Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
3
CY2020 uup Realized Gain Loss On Marketable Securities And Affiliated Investments
RealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
4634
CY2022 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
64239
CY2021 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
-26314
CY2020 uup Unrealized Gain Loss On Marketable Securities And Affiliated Investments
UnrealizedGainLossOnMarketableSecuritiesAndAffiliatedInvestments
61413
CY2022 uup Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-2267849
CY2021 uup Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
-3782485
CY2020 uup Increase Decrease In Variation Margin
IncreaseDecreaseInVariationMargin
1827703
CY2022 uup Decrease Increase In Due From Broker
DecreaseIncreaseInDueFromBroker
2034654
CY2021 uup Decrease Increase In Due From Broker
DecreaseIncreaseInDueFromBroker
-2034654
CY2022 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
2836913
CY2021 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
6673
CY2020 us-gaap Increase Decrease In Dividends Receivable
IncreaseDecreaseInDividendsReceivable
-25102
CY2022 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
749665
CY2021 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
171153
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
51169
CY2022 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-377
CY2021 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
-827
CY2020 us-gaap Increase Decrease In Payables To Broker Dealers
IncreaseDecreaseInPayablesToBrokerDealers
858
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-847628362
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-328347156
CY2022 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1754330909
CY2021 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
427447338
CY2020 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1681468713
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
853205980
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
328347156
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
181691754
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5577618
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-10505074
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10505074
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5577618
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
0
CY2022 us-gaap Interest Paid Net
InterestPaidNet
104641
CY2020 us-gaap Interest Paid Net
InterestPaidNet
6190
CY2022Q4 us-gaap General Partners Capital Account Units Outstanding
GeneralPartnersCapitalAccountUnitsOutstanding
40
CY2022 uup Treasury Obligation Measurement Maximum Maturity Period
TreasuryObligationMeasurementMaximumMaturityPeriod
P12M
CY2022 uup Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2022 uup Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;margin-left:3.33%;text-indent:-3.33%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">B.  Accounting Estimates</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Fund monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</p>
CY2021 us-gaap Distributed Earnings
DistributedEarnings
0
CY2020 us-gaap Distributed Earnings
DistributedEarnings
0
CY2022 uup Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
5.00
CY2021 uup Average Charges Paid To Broker Per Round Turn Trade Maximum
AverageChargesPaidToBrokerPerRoundTurnTradeMaximum
5.00
CY2021Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
718465017
CY2021Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
-4284830
CY2021Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
714180187
CY2021 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0076
CY2022 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
753090
CY2020 us-gaap Investment Company Contractual Fee Waived
InvestmentCompanyContractualFeeWaived
525230
CY2022 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
0
CY2022 us-gaap Due To And From Broker Dealers And Clearing Organizations Disclosure
DueToAndFromBrokerDealersAndClearingOrganizationsDisclosure
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5 - Deposits with Commodity Broker and Custodian</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund defines cash as cash held by the Custodian. There were no cash equivalents held by the Fund as of December 31, 2022 and 2021. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Fund may deposit cash, United States Treasury Obligations, T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules. The combination of the Fund’s deposits with its Commodity Broker of cash and United States Treasury Obligations and the unrealized profit or loss on open futures contracts represents the Fund’s overall equity in its broker trading account. To meet the Fund’s maintenance margin requirements, the Fund holds United States Treasury Obligations with the Commodity Broker. The Fund transfers cash to the Commodity Broker to satisfy variation margin requirements. The Fund earns interest on any excess cash deposited with the Commodity Broker and incurs interest expense on any deficit balance with the Commodity Broker. The Fund may deposit T-Bill ETFs and money market mutual funds with the Commodity Broker as margin, to the extent permissible under CFTC rules.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The brokerage agreement with the Commodity Broker provides for the net settlement of all financial instruments covered by the agreement in the event of default or termination of any one contract. The Managing Owner will utilize any excess cash held at the Commodity Broker to offset any realized losses incurred in the currency futures contracts, if available. To the extent that any excess cash held at the Commodity Broker is not adequate to cover any realized losses, a portion of the United States Treasury Obligations and T-Bill ETFs, if any, on deposit with the Commodity Broker will be sold to make additional cash available. For financial reporting purposes, the Fund offsets financial assets and financial liabilities that are subject to legally enforceable netting arrangements.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"> The Fund’s remaining cash, United States Treasury Obligations, T-Bill ETFs and money market mutual fund holdings are on deposit with the Custodian. The Fund is permitted to temporarily carry a negative or overdrawn balance in its account with the Custodian. The Fund incurs interest expense on any overdraft balance with the Custodian. Such balances, if any at period-end, are shown on the Statements of Financial Condition under the payable caption </span><span style="font-style:italic;">Due to custodian</span><span style="font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">.</span></p>
CY2022Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2021Q4 us-gaap Cash Equivalents At Carrying Value
CashEquivalentsAtCarryingValue
0
CY2022Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
666431938
CY2022Q4 uup Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
73590524
CY2022Q4 uup Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
909560064
CY2022Q4 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
1649582526
CY2022Q4 us-gaap Investment Owned Unrecognized Unrealized Appreciation Depreciation Net
InvestmentOwnedUnrecognizedUnrealizedAppreciationDepreciationNet
-7688710
CY2022Q4 us-gaap Financial Instruments Owned At Fair Value
FinancialInstrumentsOwnedAtFairValue
1641893816
CY2021Q4 us-gaap Financial Instruments Owned Us Government And Agency Obligations At Fair Value
FinancialInstrumentsOwnedUSGovernmentAndAgencyObligationsAtFairValue
92006259
CY2021Q4 uup Financial Instruments Owned Exchange Traded Fund
FinancialInstrumentsOwnedExchangeTradedFund
49855000
CY2021Q4 uup Financial Instruments Owned Money Market Mutual Fund At Fair Value
FinancialInstrumentsOwnedMoneyMarketMutualFundAtFairValue
576603758
CY2021 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
8454
CY2020 us-gaap Proceeds From Contributions From Affiliates
ProceedsFromContributionsFromAffiliates
20671
CY2022 uup Minimum Number Of Creation Units Of Shares That Can Be Purchased
MinimumNumberOfCreationUnitsOfSharesThatCanBePurchased
1
CY2022 uup Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2022 uup Minimum Number Of Creation Units Of Shares That Can Be Redeemed
MinimumNumberOfCreationUnitsOfSharesThatCanBeRedeemed
1
CY2022 uup Number Of Shares Issued Per Creation Unit
NumberOfSharesIssuedPerCreationUnit
100000
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.62
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
24.25
CY2019Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.95
CY2022 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
2.12
CY2021 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
1.55
CY2020 us-gaap Investment Company Gain Loss On Investment Per Share
InvestmentCompanyGainLossOnInvestmentPerShare
-1.63
CY2022 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.32
CY2021 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.18
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
-0.07
CY2022 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
2.44
CY2021 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
1.37
CY2020 us-gaap Investment Company Investment Income Loss From Operations Per Share
InvestmentCompanyInvestmentIncomeLossFromOperationsPerShare
-1.70
CY2022 us-gaap Investment Company Tax Return Of Capital Distribution Per Share
InvestmentCompanyTaxReturnOfCapitalDistributionPerShare
-0.25
CY2022Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
27.81
CY2021Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
25.62
CY2020Q4 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
24.25
CY2021Q4 uup Market Value Per Share
MarketValuePerShare
25.63
CY2020Q4 uup Market Value Per Share
MarketValuePerShare
24.26
CY2019Q4 uup Market Value Per Share
MarketValuePerShare
25.98
CY2022Q4 uup Market Value Per Share
MarketValuePerShare
27.81
CY2021Q4 uup Market Value Per Share
MarketValuePerShare
25.63
CY2020Q4 uup Market Value Per Share
MarketValuePerShare
24.26
CY2022 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0114
CY2021 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0072
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
-0.0028
CY2022 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0073
CY2020 us-gaap Investment Company Expense Ratio Including Voluntary Fee Waiver
InvestmentCompanyExpenseRatioIncludingVoluntaryFeeWaiver
0.0068
CY2022 uup Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
CY2021 uup Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
CY2020 uup Average Net Assets To Expenses Prior To Waivers
AverageNetAssetsToExpensesPriorToWaivers
0.0078
CY2022 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0950
CY2021 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0565
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.0655
CY2022 uup Return At Market Value
ReturnAtMarketValue
0.0946
CY2021 uup Return At Market Value
ReturnAtMarketValue
0.0565
CY2020 uup Return At Market Value
ReturnAtMarketValue
-0.0662

Files In Submission

Name View Source Status
uup-20221231_cal.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
uup-20221231_def.xml Edgar Link unprocessable
0001564590-23-002350-index-headers.html Edgar Link pending
0001564590-23-002350-index.html Edgar Link pending
0001564590-23-002350.txt Edgar Link pending
0001564590-23-002350-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
gixr5voby2jq000001.jpg Edgar Link pending
gixr5voby2jq000002.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uup-10k_20221231.htm Edgar Link pending
uup-20221231.xsd Edgar Link pending
uup-ex231_7.htm Edgar Link pending
uup-ex311_6.htm Edgar Link pending
uup-20221231_lab.xml Edgar Link unprocessable
uup-20221231_pre.xml Edgar Link unprocessable
uup-10k_20221231_htm.xml Edgar Link completed
uup-ex312_10.htm Edgar Link pending
uup-ex313_14.htm Edgar Link pending
uup-ex314_11.htm Edgar Link pending
uup-ex321_12.htm Edgar Link pending
uup-ex322_8.htm Edgar Link pending
uup-ex323_9.htm Edgar Link pending
uup-ex324_13.htm Edgar Link pending